We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Portable Sensor Rapidly Determines Extent of Eye Injury

By LabMedica International staff writers
Posted on 14 Dec 2015
Print article
Image: The new OcuCheck Biosensor can detect differences in vitamin C concentration in fluids that leak from the eye, where higher concentrations indicate a more severe injury, researchers report (Photo courtesy of L. Brian Stauffer and University of Illinois).
Image: The new OcuCheck Biosensor can detect differences in vitamin C concentration in fluids that leak from the eye, where higher concentrations indicate a more severe injury, researchers report (Photo courtesy of L. Brian Stauffer and University of Illinois).
Researchers have demonstrated a proof-of-concept for a novel point-of-care (POC) device that can quickly and inexpensively determine whether an eye injury is mild or severe. The sensor could speed efforts to determine extent of eye injury at locations such as accident sites, rural areas lacking ophthalmology specialists, and battlefields.

The new “OcuCheck Biosensor” works by measuring vitamin C levels in the fluids that coat or leak from the eye, and was developed by a team led by Prof. Dipanjan Pan, Bioengineering, University of Illinois (Champaign, IL, USA) in collaboration with Dr. Leanne Labriola, ophthalmologist at Carle (Urbana, IL, USA). “The sensor takes advantage of the fact that the ocular tear film—the viscous fluid that coats the eyeball—contains low levels of ascorbic acid, which is just vitamin C, while the interior of the eye contains much higher levels,” said Prof. Pan, “So the concept is, if there is severe damage to the eye that penetrates deeply, the ascorbic acid will leak out in high concentration.”

Currently, patients must reach a hospital to have eye injuries assessed for degree of severity. The process is often complicated, time-consuming, and imprecise. No current techniques for assessing eye injuries involve measurements of ascorbic acid (AA) “so this is a one-of-a-kind approach,” said Prof. Pan. “The new device will change the standard of care for evaluating eye traumas,” said Dr. Labriola.

OcuCheck uses graphene platelets layered 1 nm thick on filter paper. Upper layers include a unique polymer that interacts with the graphene, gold electrodes, and ascorbate oxidase, which binds to AA. “The idea is that the moment that the AA comes in and binds to the ascorbate oxidase, it will pull the polymer out of its interaction with the graphene,” changing the sensor’s electrical properties, said Prof. Pan.

Proof-of-concept was demonstrated by testing clinical samples from 16 patients undergoing eye surgery. OcuCheck coul—with high sensitivity, accuracy, and specificity—detect a range of AA concentrations. OcuCheck has not yet been tested on samples from trauma patients “but we have mixed the samples with blood, and the sensor’s sensitivity to AA is retained even in the presence of blood. The filter paper will filter out the blood,” said Prof. Pan.

The team is working with an industrial design professor to build a housing unit for the sensor. Prof. Pan and Dr. Labriola have founded a startup company, InnSight Technology, to help bring the device to market. “This is a perfect example of physicians and engineers working together to find solutions to current problems in health care,” said Prof. Pan, also referring to the Carle Illinois College of Medicine Carle Illinois College of Medicine (Urbana, IL, USA), a new engineering-based medical college soon to be established.

The paper, by Gartia MR, Misra SK et al., was published online in November 2015, in the journal Scientific Reports.

Related Links:

University of Illinois 
Carle
Carle Illinois College of Medicine


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.